29 Sep Half year 2022 results
Significant progress against post-COVID-19 growth strategy to offset expected decline in COVID-19 sales
Paris, France and Camberley, UK – 29 September 2022 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces its unaudited results for the six months ended 30 June 2022.